These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24935062)

  • 21. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells.
    Zhong X; Liu X; Li Y; Cheng M; Wang W; Tian K; Mu L; Zeng T; Liu Y; Jiang X; Yu L; Gao L; Zhou Y
    Oncotarget; 2016 Jul; 7(28):44365-44380. PubMed ID: 27259253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients].
    Sun ZF; Wang L; Gu F; Fu L; Li WL; Ma YJ
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):26-30. PubMed ID: 22490851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas.
    Brell M; Ibáñez J; Felpete A; Burguera B; Frontera M; Couce ME
    Brain Tumor Pathol; 2011 Apr; 28(2):137-44. PubMed ID: 21331614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.
    Zhang Y; Zhan H; Xu W; Yuan Z; Lu P; Zhan L; Li Q
    Pathol Res Pract; 2011 Jan; 207(1):24-9. PubMed ID: 21087829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
    Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
    Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
    Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
    Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
    Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
    J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic significance of cystatin C expression in gliomas.
    Nakabayashi H; Hara M; Shimuzu K
    Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
    Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
    Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
    Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
    Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
    Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
    Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGA2 overexpression in non-small cell lung cancer.
    Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
    Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulated expression of the clock genes in gliomas.
    Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
    Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features.
    Venkatesan N; Kandalam M; Pasricha G; Sumantran V; Manfioletti G; Ono SJ; Reddy MA; Krishnakumar S
    J Pediatr Hematol Oncol; 2009 Mar; 31(3):209-14. PubMed ID: 19262251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of CD68 and kallikrein 6 in human glioma.
    Strojnik T; Kavalar R; Zajc I; Diamandis EP; Oikonomopoulou K; Lah TT
    Anticancer Res; 2009 Aug; 29(8):3269-79. PubMed ID: 19661345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.